...
首页> 外文期刊>Acta biomaterialia >Hollow fibers of poly(lactide-co-glycolide) and poly(ε-caprolactone) blends for vascular tissue engineering applications.
【24h】

Hollow fibers of poly(lactide-co-glycolide) and poly(ε-caprolactone) blends for vascular tissue engineering applications.

机译:聚(丙交酯 - 共乙酰基)的中空纤维和血管组织工程应用的聚(ε-己内酯)共混物。

获取原文
获取原文并翻译 | 示例
           

摘要

At present the manufacture of small-diameter blood vessels is one of the main challenges in the field of vascular tissue engineering. Currently available vascular grafts rapidly fail due to development of intimal hyperplasia and thrombus formation. Poly(lactic-co-glycolic acid) (PLGA) hollow fiber (HF) membranes have previously been proposed for this application, but as we show in the present work, they have an inhibiting effect on cell proliferation and rather poor mechanical properties. To overcome this we prepared HF membranes via phase inversion using blends of PLGA with poly(ε-caprolactone) (PCL). The influence of polymer composition on the HF physicochemical properties (topography, water transport and mechanical properties) and cell attachment and proliferation were studied. Our results show that only the ratio PCL/PLGA of 85/15 (PCL/PLGA85/15) yielded a miscible blend after processing. A higher PLGA concentration in the blend led to immiscible PCL/PLGA phase-separated HFs with an inhomogeneous morphology and variation in the cell culture results. In fact, the PCL/PLGA85/15 blend, which had the most homogeneous morphology and suitable pore structure, showed better human adipose stem cell (hASC) attachment and proliferation compared with the homopolymers. This, combined with the good mechanical and transport properties, makes them potentially useful for the development of small-caliber vascular grafts.
机译:目前小直径血管的制造是血管组织工程领域的主要挑战之一。由于内膜增生和血栓形成,目前可用的血管移植迅速失效。本申请先前提出了聚(乳酸共聚乙醇酸)(PLGA)中空纤维(HF)膜,但随着我们在本作工作中展示,它们对细胞增殖和相当差的力学性能具有抑制作用。为了克服这种方法,我们通过使用Poly(ε-己内酯)(PCL)的PLGA共混物通过相反转制备HF膜。研究了聚合物组合物对HF物理化学性质(地形,水运输和机械性能)和细胞附着和增殖的影响。我们的研究结果表明,只有85/15(PCL / PLGA85 / 15)的比率PCL / PLGA(PCL / PLGA85 / 15)在加工后产生了混溶性混合物。共混物中的更高PLGGA浓度导致与细胞培养结果中不均匀形态和变异的不混溶的PCL / PLGA相分离的HFS。实际上,具有最均匀的形态和合适的孔隙结构的PCL / PLGA85 / 15共混物,与均聚物相比,具有更好的人类脂肪干细胞(HASC)附着和增殖。这与良好的机械和运输性能相结合,使得它们可能对小口径血管移植物的开发有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号